CDKN2A and oropharynx cancer: CDKN2A has been classified as a tumor suppressor, methylation studies have detected promoter hypermethylation of CDKN2A in oral and oropharyngeal cancer tissue as well in OPL; therefore CDKN2A inactivation is in part due to promoter methylation (98–102).